Cancer Biology and Oncology
A section of Biomedicines (ISSN 2227-9059).
Section Information
Scope
This section publishes reviews and original peer-reviewed papers of a high scientific standard, covering all the aspects of innovative cancer therapies. Papers aim to uncover novel therapeutic approaches toward overcoming conventional anticancer drug resistance, a better understanding of the interrelations between cancer and metabolism as well as tumor and microenvironment, along with the discovery of novel diagnostic and prognostic makers. Topics include but are not limited to in vitro and in vivo cancer therapeutic responses, targeted therapies (including metabolism and immunotherapy, such involving CAR-T cells), identification of novel therapeutic targets, and evaluation of novel diagnosis and prognosis markers and the assessment of their impact on morphological, phenotypical, and molecular classifications.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Targeting Transcription Factors and Oncogenic Proteins for Cancer Therapy (2nd Edition) (Deadline: 30 April 2025)
- Novel Approaches for Diagnosis and Treatment of Pancreatic Cancer (Deadline: 30 April 2025)
- Molecular Mechanisms of Myeloid Cell Differentiation and Resistance to Anti-Tumor Immunity (Deadline: 30 April 2025)
- Diagnosis, Pathogenesis and Treatment of Pancreatic Ductal Adenocarcinoma (Deadline: 30 April 2025)
- From Bench to Bedside: Advances in Non-small Cell Lung Cancer in the Era of Precision Oncology (Deadline: 30 April 2025)
- Thoracic Malignancies: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 30 April 2025)
- Advances in the Treatment of Kidney and Upper Urinary Tract Cancers: Second Edition (Deadline: 30 April 2025)
- Diagnostics and Therapy for Malignant Tumors: New Developments (Deadline: 30 April 2025)
- The Development of Cancer Immunotherapy (Deadline: 30 April 2025)
- Mechanisms and Novel Treatment Options for Non-Small-Cell Lung Cancer (Deadline: 30 April 2025)
- Malignant and Potentially Malignant Disorders of the Oral Cavity: Updates from Pathogenesis to Therapy 2.0 (Deadline: 30 April 2025)
- Hepatocellular Carcinoma: From Pathophysiology to Therapeutic Approaches Treatment (Deadline: 30 April 2025)
- The Role of HOX Genes in Particular Cancers (Deadline: 30 April 2025)
- Head-and-Neck Sarcomas: Exploring Ways for Their Optimal Treatment (Deadline: 30 April 2025)
- Chemoprevention to Dwindle Tumor Development (Deadline: 30 April 2025)
- Endocrine Cancers: Pathophysiology and Therapy (Deadline: 30 April 2025)
- Navigating the Tumor Microenvironment: The Role of Reactive Oxygen Species in Cancer Progression and Therapy (Deadline: 30 April 2025)
- Advances in the Pharmacology of Neuroendocrine Tumors (Deadline: 30 April 2025)
- Advances in Brain Tumor Diagnosis: Innovations and Emerging Technologies (Deadline: 30 April 2025)
- NASH and Hepatocellular Carcinoma (HCC) (Deadline: 30 April 2025)
- Molecular Regulation of Cancer Progression and Metastasis to Identify Novel Treatment Strategies (Deadline: 31 May 2025)
- Prostate Cancer: From Pathology to Novel Therapeutic Approaches (2nd Edition) (Deadline: 31 May 2025)
- Colorectal Cancer: Diagnostic, Pathophysiology and Therapeutic Approaches (Deadline: 31 May 2025)
- Advances of Autophagy in Human Cancers and Tumors (Deadline: 31 May 2025)
- Advancements and Challenges in Anticancer Targeted Therapy with Small Molecules (Deadline: 31 May 2025)
- Antibody–Drug Conjugates and Cancer Immunotherapy (Deadline: 31 May 2025)
- Drug Resistance and Novel Targets for Cancer Therapy—Second Edition (Deadline: 31 May 2025)
- Genomic Insights and Translational Opportunities for Human Cancers (Deadline: 31 May 2025)
- New Insights into Breast Cancer Management: From Tumorigenesis to Personalized Treatments (Deadline: 31 May 2025)
- CDK Inhibitors: A New Wave of Therapeutic Agents for Human Diseases (Deadline: 31 May 2025)
- Killing It Softly–New Approaches to Overcome Cancer Chemoresistance 2.0 (Deadline: 31 May 2025)
- Unraveling the Role of Glucocorticoid Receptor in Inflammation and Cancer (Deadline: 30 June 2025)
- New Insights into Upper Tract Urothelial Carcinoma: What Changed? (Deadline: 30 June 2025)
- Advances in Therapeutic Strategies in Gynecological Malignant Tumors—2nd Edition (Deadline: 30 June 2025)
- Pancreatic Cancer: From Mechanisms to Therapeutic Approaches (3rd Edition) (Deadline: 30 June 2025)
- Recent Advances in Lymphoma: Second Edition (Deadline: 30 June 2025)
- Applications of Plasma in Cancer Treatment and Physiology (Deadline: 30 June 2025)
- Mitochondrion-Targeting Agents for Tumor Therapy (Deadline: 30 June 2025)
- Triple Negative Breast Cancer: From Mechanisms to Therapeutic Approaches (Deadline: 30 June 2025)
- Nanoparticle-Based Therapeutic Delivery Systems in Cancer Therapy (Deadline: 30 June 2025)
- Glioblastoma: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 30 June 2025)
- Novel Strategies for Oncogene-Addicted Lung Cancers: Not Rare Anymore (Deadline: 31 July 2025)
- Novel Progress in Cancer Immunotherapy (Deadline: 31 July 2025)
- Advances in Precision Cancer Therapy (Deadline: 31 July 2025)
- Biochemical and Molecular Perspectives on Engineered Nanoparticles for Cancer Therapy (Deadline: 31 July 2025)
- Advances in Head and Neck Cancer: Mechanisms, Diagnosis, and Therapeutic Progress (Deadline: 31 July 2025)
- Extracellular Vesicles: Research Advances in Cancer Treatment and Diagnostics (Deadline: 31 July 2025)
- New Insights into the Diagnosis and Treatment of Breast Cancer (Deadline: 31 July 2025)
- Advances in Lung Cancer: From Bench to Bedside (Deadline: 31 July 2025)
- Autophagy, Apoptosis and Cancer: 2025 Update (Deadline: 31 July 2025)
- Mechanisms and Novel Therapeutic Approaches for Gliomas (Deadline: 31 July 2025)
- Recent Advances in Primary and Relapsed Ovarian Cancer (Deadline: 31 July 2025)
- Biomarkers and Therapeutic Targets in Gastric Cancer: From Basic Research to Clinical Applications (Deadline: 31 July 2025)
- Genetic Insights and Pharmacogenomic Approaches in Cancer Treatment (Deadline: 31 August 2025)
- Emerging Trends in Malignant Mesothelioma (Deadline: 31 August 2025)
- Epigenetics and Immune Perspectives in Cancer: Overcoming Therapy Resistance (Deadline: 31 August 2025)
- Meningioma: Novel Diagnostic and Therapeutic Approaches (Deadline: 31 August 2025)
- Head and Neck Cancer: From Mechanisms to Therapeutic Approaches—Advances and Challenges (Deadline: 31 August 2025)
- Tumor Biomarkers in Gynecology—2nd Edition (Deadline: 31 August 2025)
- Roles of Extracellular Vesicles in Cancer Immunotherapy (Deadline: 31 August 2025)
- MicroRNAs as Mediators of Tumor Cell State Transitions, Receptor Remodeling, Drug Resistance, and Systemic Metastasis (Deadline: 31 August 2025)
- Role of Bone Marrow Niche in Haematological Cancers (Deadline: 31 August 2025)
- Drug Resistance and Tumor Microenvironment in Human Cancers (Deadline: 31 August 2025)
- The Role of Environmental Pollutants in Cancer and Chemoresistance (Deadline: 31 August 2025)
- Advancements in Artificial Intelligence (AI) for Cancer Genomics and Genetics (Deadline: 31 August 2025)
- Mechanisms and Therapeutic Approaches for Hepatocellular Carcinoma (Deadline: 31 August 2025)
- Advances in Cancer Biology and Experimental Anticancer Therapies (2nd Edition) (Deadline: 31 August 2025)
- Peptide Therapeutic Approaches for Cancer Treatment (Deadline: 31 August 2025)
- Matrix Biology Insights: Unraveling the Role of Proteinases, Fibroblasts, and Extracellular Matrix Metalloproteinase Inducer in the Tumor Microenvironment (Deadline: 30 September 2025)
- Advances in Immunotherapy and Radiation Therapy for Cancer (2nd Edition) (Deadline: 30 September 2025)
- Advances in Therapeutic Strategies and Precision Medicine in Solid Tumors and Metastasis—2nd Edition (Deadline: 30 September 2025)
- Immunotherapy and Targeted Treatment in Solid Tumors: Biomarkers and Novel Therapeutic Strategies (Deadline: 30 September 2025)
- Diagnostic and Therapeutic Approaches to Pancreatic Cancer—Second Edition (Deadline: 30 September 2025)
- New Advances in Ovarian Cancer (Deadline: 30 September 2025)
- Lymphomas: From Mechanisms to Therapeutic Approaches (Deadline: 30 September 2025)
- Advances in Oral Squamous Cell Carcinoma Research (Deadline: 30 September 2025)
- Advanced Research in Thyroid and Parathyroid Diseases (Deadline: 30 September 2025)
- Prostate Cancer Pathology: Recent Advances and Future Perspectives (Deadline: 30 September 2025)
- Advancements in Lung Cancer Precision Oncology Research and Treatments (Deadline: 30 September 2025)
- Hepato-Pancreato-Biliary Cancers: Pathogenesis, Comorbidities and Therapy Updated (Deadline: 30 September 2025)
- Multidisciplinary Management of Rare Head and Neck Tumors: The Importance of Knowing and Dealing with Them (Deadline: 30 September 2025)
- The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances (Deadline: 30 September 2025)
- Advanced Cancer Diagnosis and Treatment: Third Edition (Deadline: 30 September 2025)
- Glioma Therapy: Current Status and Future Prospects (Deadline: 31 October 2025)
- Emerging Trends in Cancer: Biomarkers, Therapeutic Strategies and Future Directions (Deadline: 31 October 2025)
- An Update on Mechanisms and Treatments for Thyroid Cancer in Current Oncology, 2nd Edition (Deadline: 31 October 2025)
- Head and Neck Tumors, 4th Edition (Deadline: 31 October 2025)
- Cancer-Associated Thrombosis: From Biomarkers to Diagnostic and Therapeutic Strategies to Optimize Treatment (Deadline: 31 October 2025)
- Tumor Microenvironment in Cancer: Basic Science, Artificial Intelligence, and Clinical Research (Deadline: 31 October 2025)
- Strategies for Anticancer in p53 Mutated Cancers (Deadline: 31 October 2025)
- Past, Present and Further Looking for Therapeutic Management of Pancreatic Ductal Adenocarcinoma (2nd Edition) (Deadline: 31 October 2025)
- Advances in Liver Oncology: Molecular Mechanisms and Therapeutic Innovations (Deadline: 31 October 2025)
- Hepatocellular Carcinoma Pathogenesis and Therapy (Deadline: 31 October 2025)
- Breast Cancer: New Diagnostic and Therapeutic Approaches (Deadline: 31 October 2025)
- Prostate Cancer Targeted Therapy: Highlighting Advances in Precision Medicine and Rational Combination Approaches (Deadline: 31 October 2025)
- Two Decades of Advances in Colorectal Cancer Prevention and Treatment: From Aspirin to Precision Oncology (Deadline: 30 November 2025)
- New Insights in Radiotherapy: Bridging Radiobiology and Oncology (Deadline: 30 November 2025)
- Pediatric Tumors: Diagnosis, Pathogenesis, Treatment, and Outcome (Deadline: 30 November 2025)
- State-of-the-Art Endocrine Cancer Biology and Oncology (Deadline: 30 November 2025)
- Therapeutic Resistance in Oral Cancer: Mechanisms, Biomarkers, and Novel Strategies to Restore Treatment Responses (Deadline: 30 November 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Autophagy in Cancer and Metastasis
- Feature Papers in Cancer Biology and Therapeutics
- Hereditary Gastrointestinal Cancer Syndromes: Molecular Basis of Onset and Progression, Molecular Diagnosis, and Precision Therapy
- Stem Cells and Cancer Therapeutics (Closed)
- Targeting Cell Metabolism as Cancer Therapy (Closed)
